Skip to content
CLINICAL RESEARCH SERVICES PARTNER

HEMATOLOGY &
ONCOLOGY

HEMATOLOGY &
ONCOLOGY

SINGULAR FOCUS. UNMATCHED DELIVERY.

SINGULAR FOCUS. UNMATCHED DELIVERY.

The clinical research services partner specializing in hematologic malignancies and solid tumors, from Phase II through Phase IV.

The clinical research services partner specializing in hematologic malignancies and solid tumors, from Phase II through Phase IV.

Let’s Talk
Capabilities

PHASE II-IV

PHASE II-IV

PHASE II-IV

SOLID TUMORS

SOLID TUMORS

SOLID TUMORS

HEMATOLOGIC MALIGNANCIES

HEMATOLOGIC MALIGNANCIES

HEMATOLOGIC MALIGNANCIES

CELL & GENE THERAPY

CELL & GENE THERAPY

CELL & GENE THERAPY

ADAPTIVE TRIAL DESIGNS

ADAPTIVE TRIAL DESIGNS

CLINICAL RESEARCH SERVICES PARTNER

HEMATOLOGY &
ONCOLOGY

SINGULAR FOCUS. UNMATCHED DELIVERY.

The clinical research services partner specializing in hematologic malignancies and solid tumors, from Phase II through Phase IV.

Let’s Talk
Capabilities

PHASE II-IV

SOLID TUMORS

HEMATOLOGIC MALIGNANCIES

CELL & GENE THERAPY

ADAPTIVE TRIAL DESIGNS

FIG. 01 / THE CAPABILITY SYSTEM

CAPABILITY SYSTEM

THE OPERATING MODEL

Six service lines.
One accountable delivery structure.

Six service lines.
One accountable delivery structure.

Six service lines.
One accountable delivery structure.

Six service lines.
One accountable delivery structure.

KARAMATA brings specialized capabilities together within a delivery structure built for hematology and oncology. Each workstream has a defined owner. Decision paths are explicit. When work moves between functions, its context, responsibility, and open issues move with it.

KARAMATA brings specialized capabilities together within a delivery structure built for hematology and oncology. Each workstream has a defined owner. Decision paths are explicit. When work moves between functions, its context, responsibility, and open issues move with it.

KARAMATA brings specialized capabilities together within a delivery structure built for hematology and oncology. Each workstream has a defined owner. Decision paths are explicit. When work moves between functions, its context, responsibility, and open issues move with it.

KARAMATA brings specialized capabilities together within a delivery structure built for hematology and oncology. Each workstream has a defined owner. Decision paths are explicit. When work moves between functions, its context, responsibility, and open issues move with it.

Stop managing handoffs. Start driving outcomes.

EXPLORE CAPABILITIES

CAPABILITY CATEGORY

OPERATING SCOPE

01

Trial Operations & Site Management

Trial Operations & Site Management

Trial Operations & Site Management

HEMATOLOGY + ONCOLOGY

02

Patient Recruitment & Retention

Patient Recruitment & Retention

Patient Recruitment & Retention

HEMATOLOGY + ONCOLOGY

03

Study Start-Up & Documentation

Study Start-Up & Documentation

Study Start-Up & Documentation

HEMATOLOGY + ONCOLOGY

04

Data Management & Integrity

Data Management & Integrity

Data Management & Integrity

HEMATOLOGY + ONCOLOGY

05

Clinical Research Finance

Clinical Research Finance

Clinical Research Finance

ALL THERAPEUTIC AREAS

06

Regulatory Disclosure

Regulatory Disclosure

Regulatory Disclosure

ALL THERAPEUTIC AREAS

FIG. 02 / THE STRUCTURAL DIFFERENCE

Your trial should determine the model, not your account size.

Your trial should determine the model, not your account size.

Your trial should determine the model, not your account size.

Your trial should determine the model, not your account size.

Big CROs are built for Big Pharma.

Big CROs are built for Big Pharma.

Big CROs are built for Big Pharma.

Big CROs are built for Big Pharma.

Attention and resources follow account size, while trials move through legacy delivery layers and one-size-fits-all processes.

Attention and resources follow account size, while trials move through legacy delivery layers and one-size-fits-all processes.

Attention and resources follow account size, while trials move through legacy delivery layers and one-size-fits-all processes.

Attention and resources follow account size, while trials move through legacy delivery layers and one-size-fits-all processes.

KARAMATA takes a different approach.

KARAMATA takes a different approach.

KARAMATA takes a different approach.

KARAMATA takes a different approach.

We build senior-led, purpose-fit teams around the requirements of your protocol, creating clear accountability, direct visibility, and fewer layers between your team and the work.

We build senior-led, purpose-fit teams around the requirements of your protocol, creating clear accountability, direct visibility, and fewer layers between your team and the work.

We build senior-led, purpose-fit teams around the requirements of your protocol, creating clear accountability, direct visibility, and fewer layers between your team and the work.

We build senior-led, purpose-fit teams around the requirements of your protocol, creating clear accountability, direct visibility, and fewer layers between your team and the work.

You retain authority over the strategic decisions that shape your trial.

You retain authority over the strategic decisions that shape your trial.

You retain authority over the strategic decisions that shape your trial.

You retain authority over the strategic decisions that shape your trial.

We provide the precision and execution necessary to move it forward.

We provide the precision and execution necessary to move it forward.

We provide the precision and execution necessary to move it forward.

We provide the precision and execution necessary to move it forward.

01 / OWNERSHIP

Named accountability for every agreed workstream.

Named accountability for every agreed workstream.

Named accountability for every agreed workstream.

02 / CONTINUITY

Context and open decisions move with the work.

Context and open decisions move with the work.

Context and open decisions move with the work.

03 / AUTHORITY

We prepare and coordinate. You decide, approve, and release.

We prepare and coordinate. You decide, approve, and release.

We prepare and coordinate. You decide, approve, and release.

FIG. 03 / REGULATORY DISCLOSURE

REGULATORY DISCLOSURE / ALL THERAPEUTIC AREAS

REGULATORY DISCLOSURE / ALL THERAPEUTIC AREAS

REGULATORY DISCLOSURE / ALL THERAPEUTIC AREAS

REGULATORY DISCLOSURE / ALL THERAPEUTIC AREAS

ClinicalTrials.gov Disclosure Services

ClinicalTrials.gov Disclosure Services

ClinicalTrials.gov Disclosure Services

ClinicalTrials.gov Disclosure Services

Keep your record current, complete, and compliant.

Keep your record current, complete, and compliant.

Keep your record current, complete, and compliant.

KARAMATA prepares and maintains ClinicalTrials.gov registration and results records within your organization’s PRS account, manages approved updates, and addresses QC comments. Your Responsible Party retains responsibility for release and certification.

KARAMATA prepares and maintains ClinicalTrials.gov registration and results records within your organization’s PRS account, manages approved updates, and addresses QC comments. Your Responsible Party retains responsibility for release and certification.

KARAMATA prepares and maintains ClinicalTrials.gov registration and results records within your organization’s PRS account, manages approved updates, and addresses QC comments. Your Responsible Party retains responsibility for release and certification.

KARAMATA prepares and maintains ClinicalTrials.gov registration and results records within your organization’s PRS account, manages approved updates, and addresses QC comments. Your Responsible Party retains responsibility for release and certification.

EXPLOREREGULATORY DISCLOSURE SERVICES→  EXPLORE
Two clinical research professionals reviewing study records together at a conference table.
Two clinical research professionals reviewing study records together at a conference table.
Two clinical research professionals reviewing study records together at a conference table.

DISCLOSURE WORKSTREAM

FIG. 04 / CLINICAL RESEARCH FINANCE

Two clinical research finance specialists reviewing trial budget systems together
Two clinical research finance specialists reviewing trial budget systems together
Two clinical research finance specialists reviewing trial budget systems together

CLINICAL RESEARCH FINANCE / ALL THERAPEUTIC AREAS

CLINICAL RESEARCH FINANCE / ALL THERAPEUTIC AREAS

CLINICAL RESEARCH FINANCE / ALL THERAPEUTIC AREAS

CLINICAL RESEARCH FINANCE / ALL THERAPEUTIC AREAS

The protocol sets the terms. We make the finances follow.

The protocol sets the terms. We make the finances follow.

The protocol sets the terms. We make the finances follow.

The protocol sets the terms. We make the finances follow.

Coverage analysis, billing grids, sponsor budgets, agreements, REC forms, CTMS build, and amendment support—carried through one accountable workstream.

Coverage analysis, billing grids, sponsor budgets, agreements, REC forms, CTMS build, and amendment support—carried through one accountable workstream.

Coverage analysis, billing grids, sponsor budgets, agreements, REC forms, CTMS build, and amendment support—carried through one accountable workstream.

Coverage analysis, billing grids, sponsor budgets, agreements, REC forms, CTMS build, and amendment support—carried through one accountable workstream.

EXPLORECLINICAL RESEARCH FINANCE SERVICES

FINANCE WORKSTREAM

FIG. 05 / PATIENT PARTICIPATION

RECRUITMENT MODEL

PATIENT RECRUITMENT & RETENTION

PATIENT RECRUITMENT & RETENTION

Patient Recruitment doesn’t have to be so complicated. Flip the switch.

Patient Recruitment doesn’t have to be so complicated. Flip the switch.

Patient Recruitment doesn’t have to be so complicated. Flip the switch.

Patient Recruitment doesn’t have to be so complicated. Flip the switch.

5to95™ Patient Recruitment & Retention helps sponsors and sites turn fragmented outreach, screening, enrollment, and follow-up into a coordinated path to participation—reaching beyond the few patients already within the clinical-trial system to the many who remain outside it.

5to95™ Patient Recruitment & Retention helps sponsors and sites turn fragmented outreach, screening, enrollment, and follow-up into a coordinated path to participation—reaching beyond the few patients already within the clinical-trial system to the many who remain outside it.

5to95™ Patient Recruitment & Retention helps sponsors and sites turn fragmented outreach, screening, enrollment, and follow-up into a coordinated path to participation—reaching beyond the few patients already within the clinical-trial system to the many who remain outside it.

5to95™ Patient Recruitment & Retention helps sponsors and sites turn fragmented outreach, screening, enrollment, and follow-up into a coordinated path to participation—reaching beyond the few patients already within the clinical-trial system to the many who remain outside it.

Explore 5to95™

START A CONVERSATION

A KARAMATA team member listening during a trial-planning conversation

Talk to us about your trial.

Talk to us about your trial.

Talk to us about your trial.

Talk to us about your trial.

Wherever you are in the process, we’d love to learn more and help move your trial forward.

Wherever you are in the process, we’d love to learn more and help move your trial forward.

Wherever you are in the process, we’d love to learn more and help move your trial forward.

Wherever you are in the process, we’d love to learn more and help move your trial forward.

Let’s Talk→  24 HOUR RESPONSE
KARAMATA
ADDRESS
3101 N. Central Ave. Ste 183 #6830
Phoenix, AZ 85012
© 2026 KARAMATA LLC.
ALL RIGHTS RESERVED.
Accountable trials. Delivered.™
ONCOLOGY & HEMATOLOGY TRIAL SERVICES